197 related articles for article (PubMed ID: 18166079)
1. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
Maillard PV; Reynard S; Serhan F; Turelli P; Trono D
PLoS Pathog; 2007 Dec; 3(12):e200. PubMed ID: 18166079
[TBL] [Abstract][Full Text] [Related]
2. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
Oliveira NM; Trikha R; McKnight Á
Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
[TBL] [Abstract][Full Text] [Related]
3. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
Ulm JW; Perron M; Sodroski J; C Mulligan R
Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
[TBL] [Abstract][Full Text] [Related]
4. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
Perron MJ; Stremlau M; Lee M; Javanbakht H; Song B; Sodroski J
J Virol; 2007 Mar; 81(5):2138-48. PubMed ID: 17135314
[TBL] [Abstract][Full Text] [Related]
5. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
Perron MJ; Stremlau M; Sodroski J
J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
[TBL] [Abstract][Full Text] [Related]
6. An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding.
Sebastian S; Grütter C; Strambio de Castillia C; Pertel T; Olivari S; Grütter MG; Luban J
J Virol; 2009 Apr; 83(7):3365-73. PubMed ID: 19153241
[TBL] [Abstract][Full Text] [Related]
7. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
[TBL] [Abstract][Full Text] [Related]
8. SUMO-interacting motifs of human TRIM5α are important for antiviral activity.
Arriagada G; Muntean LN; Goff SP
PLoS Pathog; 2011 Apr; 7(4):e1002019. PubMed ID: 21490953
[TBL] [Abstract][Full Text] [Related]
9. A comparison of murine leukemia viruses that escape from human and rhesus macaque TRIM5αs.
Ohkura S; Stoye JP
J Virol; 2013 Jun; 87(11):6455-68. PubMed ID: 23536686
[TBL] [Abstract][Full Text] [Related]
10. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
[TBL] [Abstract][Full Text] [Related]
11. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
[TBL] [Abstract][Full Text] [Related]
12. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.
Perez-Caballero D; Hatziioannou T; Yang A; Cowan S; Bieniasz PD
J Virol; 2005 Jul; 79(14):8969-78. PubMed ID: 15994791
[TBL] [Abstract][Full Text] [Related]
13. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
[TBL] [Abstract][Full Text] [Related]
14. Binding of the rhesus TRIM5α PRYSPRY domain to capsid is necessary but not sufficient for HIV-1 restriction.
Yang Y; Brandariz-Nuñez A; Fricke T; Ivanov DN; Sarnak Z; Diaz-Griffero F
Virology; 2014 Jan; 448():217-28. PubMed ID: 24314652
[TBL] [Abstract][Full Text] [Related]
15. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
[TBL] [Abstract][Full Text] [Related]
16. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
Sastri J; Campbell EM
AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
[TBL] [Abstract][Full Text] [Related]
17. Murine double minute 2 as a modulator of retroviral restrictions mediated by TRIM5alpha.
Malbec M; Pham QT; Plourde MB; Létourneau-Hogan A; Nepveu-Traversy ME; Berthoux L
Virology; 2010 Sep; 405(2):414-23. PubMed ID: 20619429
[TBL] [Abstract][Full Text] [Related]
18. TRIM5α Degradation via Autophagy Is Not Required for Retroviral Restriction.
Imam S; Talley S; Nelson RS; Dharan A; O'Connor C; Hope TJ; Campbell EM
J Virol; 2016 Jan; 90(7):3400-10. PubMed ID: 26764007
[TBL] [Abstract][Full Text] [Related]
19. Homology-based identification of capsid determinants that protect HIV1 from human TRIM5α restriction.
Maillard PV; Zoete V; Michielin O; Trono D
J Biol Chem; 2011 Mar; 286(10):8128-8140. PubMed ID: 21169362
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.
Song B; Javanbakht H; Perron M; Park DH; Stremlau M; Sodroski J
J Virol; 2005 Apr; 79(7):3930-7. PubMed ID: 15767395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]